Governmental Partners

RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.

  • RegMed XB is proud to combine the Public and Private domain and believes that to really make a difference for chronically ill patients we need to switch from palliative care to producing cures. It is a high priority of the (inter)national and local governments to enhance the quality of life of its citizens, stimulate the (local) economies by creating new businesses and facilitate a new world-class ecosystem around the Regenerative Medicine (RM) industry. RegMed XB is backed by national and local governments to de-risk these promising concepts from academia to a proof of concept or first clinical trial level before other commercial partners take over and realize market introduction.